antifungal resistance – Page 7

Targeted long-read sequencing analysis and antifungal susceptibility profiles of Sporothrix schenckii isolates from Thailand

mycolabadmin

Researchers in Thailand studied a fungal infection called sporotrichosis by using advanced DNA sequencing technology to identify the exact species and understand how different strains are related to each other. They found that while current treatment options work, some strains are becoming resistant to the main drug used (itraconazole). The study shows that a newer, faster DNA sequencing method can be just as reliable as traditional methods for identifying these dangerous fungi and tracking how they spread between cats and humans.

Pathogenic mucorales: Deciphering their cell wall polysaccharidome and immunostimulatory potential

mycolabadmin

Researchers studied three dangerous fungi that cause serious infections called mucormycosis. They examined the outer coating of these fungi, called the cell wall, which is made of sugar-like molecules called polysaccharides. When these fungi were exposed to human immune cells, they triggered strong inflammatory responses. Understanding these fungal components could help develop better treatments and vaccines for this life-threatening infection.

Neonatal Invasive Candidiasis: Current Concepts

mycolabadmin

Neonatal invasive candidiasis is a serious fungal infection affecting premature and very low birth weight babies. The types of fungi causing these infections are changing globally, with more resistant strains appearing, especially in lower-income countries. Treatment options are limited by this resistance, making prevention through hygiene and proper hospital practices increasingly important.

Leveraging synthetic genetic array screening to identify therapeutic targets and inhibitors for combatting azole resistance in Candida glabrata

mycolabadmin

Candida glabrata is a dangerous fungus causing serious infections that is becoming resistant to antifungal drugs. Researchers used a genetic screening technique to find genes that interact with drug resistance mutations and identified methotrexate (a drug already used for arthritis) as a potential partner for fluconazole treatment. When combined, these drugs work better together against resistant strains of the fungus, offering hope for treating these stubborn infections.

Insights into Persian Gulf Beach Sand Mycobiomes: Promises and Challenges in Fungal Diversity

mycolabadmin

Researchers studied fungi in beach sand and water along the Persian Gulf and Sea of Oman coasts during summer months. They found high levels of potentially harmful fungi, especially Aspergillus terreus, which can cause serious respiratory infections. Many of these fungi showed resistance to common antifungal medications. The study recommends better hygiene awareness for beach visitors and establishing safety standards for these popular recreational areas.

Emergence of resistant dermatophytosis caused by Trichophyton indotineae: First case series in Thailand

mycolabadmin

Researchers in Thailand identified five patients with a new type of fungal skin infection caused by Trichophyton indotineae, a species that resists the common antifungal drug terbinafine. These infections appeared as rashes on various parts of the body and required treatment with alternative medications like itraconazole. The findings represent the first confirmed cases in Thailand and suggest this resistant fungus may be spreading globally. The study also showed that a simple urease test could help doctors identify this resistant strain quickly without waiting for complex genetic testing.

Do farnesol and tyrosol production in Candidozyma auris biofilms reflect virulence potential?

mycolabadmin

Researchers discovered that a dangerous fungus called Candidozyma auris produces signaling molecules called farnesol and tyrosol in biofilms. These molecules appear to be linked to how dangerous the fungus is—strains that produce more of these molecules were more virulent in infection studies. Understanding these signaling molecules could help develop new strategies to fight this drug-resistant pathogen.

Functional Amyloids in Adhesion of Non-albicans Candida Species

mycolabadmin

Candida fungi cause common infections and form tough biofilms that resist treatment. These fungi stick to body surfaces using proteins called adhesins that form amyloid-like structures. Researchers found that special peptides can block these amyloid structures in several Candida species, preventing them from sticking to cells and potentially offering a new way to fight these infections.

Prevalence of Candida and Other Yeasts in Vulvovaginal Infections during Pregnancy: A 10-Year Serbian Survey

mycolabadmin

This 10-year study from Serbia examined vaginal yeast infections in nearly 2,200 pregnant women. Researchers found that yeast infections occurred in about 48% of symptomatic pregnant women, with Candida albicans being the most common cause. Importantly, the study discovered that other yeast species are increasingly important in these infections, and new identification methods (MALDI-TOF MS) revealed these species are often misidentified by traditional laboratory methods. The findings suggest that accurate yeast identification is essential for choosing the right treatment during pregnancy.

Spread of Antifungal-Resistant Trichophyton indotineae, United Kingdom, 2017–2024

mycolabadmin

A dangerous fungal infection called Trichophyton indotineae is rapidly spreading across the United Kingdom, particularly among people with connections to South Asia. This infection causes stubborn skin rashes that don’t respond well to common antifungal treatments like terbinafine. The number of cases has skyrocketed, making up 38% of all dermatophyte infections by 2024, and doctors need to be aware of this emerging threat.

Research Topic: antifungal resistance